ALLIANCE A051301

Primary Category:

Treatment Protocols

Disease Category:

Diffuse Large B-cell Lymphoma, Lymphoma, Non-Hodgkin Lymphoma

Status:

Temporarily Closed

A Randomized Double-Blind Phase III Study of Ibrutinib During and Following Autologous Stem Cell Transplantation Versus Placebo in Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma of the Activated B-cell Subtype

Eligible for screening study DCP 001

NCT#02443077

EFFECTIVE IMMEDIATELY, Friday, August 24, 2018, A051301 will be temporarily
suspended to new patient pre-registration (Step 0). Eligible patients who are currently
pre-registered may proceed to registration (Step 1).

Site Delegation of Tasks Log required prior to registration of any patients.